Meteospasmyl

Alverine citrate, the active ingredient in Meteospasmyl, is an antispasmodic presented as an oral formulation for gastrointestinal use. It relaxes smooth muscle to relieve abdominal pain, intestinal spasm, flatulence and related functional bowel disorders, often combined with simethicone for gas relief.

GNH USA supplies Meteospasmyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Meteospasmyl, an antispasmodic/antiflatulent combination, acts on functional gastrointestinal disorders to relieve spasm and gas. - Abdominal pain: reduces pain associated with gastrointestinal spasm. - Intestinal spasm: relaxes smooth muscle to ease cramping. - Flatulence: facilitates elimination of intestinal gas. - Irritable bowel syndrome: alleviates IBS‑related cramping and bloating. - Functional bowel disorders: improves overall discomfort and motility.

Meteospasmyl may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset. - Headache: occasional tension‑type headache. - Dizziness: brief light‑headed sensation. - Abdominal discomfort: mild cramping or fullness.

Serious or Rare Side Effects: - Rash or urticaria: signs of allergic reaction. - Swelling of face, lips or tongue: possible angioedema. - Difficulty breathing: potential severe hypersensitivity. - Severe constipation: marked reduction in bowel movements.

Before using Meteospasmyl, consider the following precautions. - Assess renal or hepatic impairment: adjust use if organ function is compromised. - Known hypersensitivity: avoid if patient is allergic to alverine citrate or simethicone. - Gastrointestinal obstruction: do not use in complete blockage. - Monitor for allergic signs: discontinue if rash, swelling or breathing difficulty occurs. - Do not exceed recommended duration without medical review. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Meteospasmyl can interact with other medicines; awareness of the level of interaction helps manage risk.

Major Interactions (Avoid): - Concomitant anticholinergic agents (e.g., atropine): may cause excessive antispasmodic effect. - Use with other antispasmodics: increased risk of gastrointestinal motility disturbances.

Moderate Interactions (Monitor Closely): - CYP3A4 substrates: alverine may alter metabolism of drugs processed by this pathway. - Antihistamines: combined dry‑mouth effects. - Alcohol: may enhance dizziness or drowsiness. - Anticoagulants: monitor if simethicone affects absorption of oral anticoagulants.